The Latest Breaking News from Mylan

Today, we’re looking at two covered call examples on Pfizer stock. The first step to finding our covered call candidates is to use the Stock Scanner with the following parameters:

Selling cash secured puts on stocks an investor is happy to take ownership of is a great way to generate some extra income.

Should Sen. Joe Manchin III seek reelection next year, the West Virginia Democrat would almost certainly rely on a network of K Street lobbyists, corporate executives and out-of-state donors to help fund his campaign.

Sen. Joe Manchin has a $9 million campaign account but could face heat for raising less than 2 percent in his home state of West Virginia.

Measles, tough weeds, and a COVID hoax.

While it's surely not worth dwelling over, it nonetheless merits note: The highest-paid CEOs and their top-level colleagues rake in more money in one year — typically way more — than most of us will see in a lifetime.

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Viatris Inc (NASDAQ: VTRS), previously known as Mylan, has 

Biocon Biologics Ltd has agreed to acquire Viatris Inc's (NASDAQ:VTRS) biosimilars assets for up to $3.335 billion in stock and cash. The deal value includes cash of up to $2.335 billion and Compulsorily Convertible Preference Shares in Biocon Biologics, valued at $1 billion. Viatris will also pay $50 million to Biocon Biologics to fund…